(Reuters) -Johnson & Johnson mentioned on Tuesday Chief Scientific Officer Paul Stoffels, who spearheaded the event of the corporate’s single-shot COVID-19 vaccine, will retire on the finish of this 12 months.
The healthcare conglomerate didn’t instantly identify Stoffels’ successor.
The announcement marks the second prime administration change at J&J (NYSE:) in current months. In August, the corporate mentioned Joaquin Duato will succeed long-standing Chief Government Officer Alex Gorsky.
Stoffels, who labored at J&J’s Janssen unit within the early Nineties, re-joined J&J in 2002 when the drugmaker acquired Virco and Tibotec, a Belgium-based drug developer, to develop its pipeline for HIV medicine.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or injury because of reliance on the data together with information, quotes, charts and purchase/promote alerts contained inside this web site. Please be totally knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding varieties potential.